Aristotle University Of Thessaloniki (AUTH)
Νανοδομημένα συστήματα μεταφοράς φαρμάκων με δυνατότητα διαπέρασης των βλεννωδών ιστών
Abstract
dc:descriptionThe purpose of this research project was to investigate the development of feasible mucus penetrating drug delivery systems in order to enhance the bioavailability of many therapeutic macromolecules. Mucus poses a dynamic semi-permeable barrier, which enables the exchange of nutrients, water, gases etc., while it simultaneously constitutes an impermeable barrier to most bacteria and pathogens. However, mucus elaborate architecture can also lead to the immobilization of macromolecules, hindering their passage and further absorption through the epithelium. Therefore, the scientific interest has focused on the development of functional nanocarriers, which has the ability to overcome this critical barrier and enhance the oral delivery of many macromolecular drugs.In the present study, mucus permeating self-nanoemulsifying drug delivery systems (SNEDDS) were developed as vehicles for the controlled oral delivery of insulin and PEP356 peptide. The design of this delivery system consisted of several combinations of oil/surfactant/cosurfactant in order to evaluate the self-nanoemulsifying performance of various excipients. An extensive experimental study was performed in order to assess the physicochemical properties of SNEDDS (i.e., average droplet size, in vitro cytotoxicity, in vitro permeability etc.) and select the most promising candidates for the incorporation of insulin or PEP356 peptide. Hydrophobic ion pairing was applied for the synthesis of protein/peptide complexes with an anionic phospholipid (DMPG) in order to improve drug solubility in SNEDDS. Drug-loaded SNEDDS were evaluated with respect to drug loading, release of the drug and drug protection against enzymatic degradation. The results demonstrated that the developed SNEDDS could be considered as novel delivery systems for the oral administration of peptides and proteins.Additionally, functional mucus permeating nanoparticles were synthesized, using poly(lactic-co-glycolic acid) (PLGA) polymer modified with polyethylene glycol (PEG). A promising hypothesis prevails that coating particles with a high PEG density can efficiently reduce particle-mucus adhesive interactions, since the hydrophilic PEG can effectively shield the hydrophobic core of the PLGA polymer. Accordingly, various PLGA-PEG copolymers were synthesized via the carbodiimide method and were evaluated in terms of the final PEG:PLGA molar ratio. Subsequently, PLGA-PEG nanoparticles were synthesized by the double emulsion method and were evaluated in comparison with unmodified PLGA nanoparticles (i.e., average size, zeta-potential, stability, in vitro cytotoxicity, in vitro permeability etc.). PLGA-PEG nanoparticles presented improved characteristics compared to unmodified nanoparicles with respect to their mucus permeability. The results showed that these functional nanoparticles exhibited higher mucus penetration rates in comparison with blank PLGA nanoparticles, indicating the reduction of adhesive interactions with mucus due to their high PEG surface coverage.Finally, a mucolytic approach was also performed in order to further enhance the permeability of PLGA-PEG nanoparticles. Mucolytic agents tend to disrupt the barrier properties of the mucus layer, thus affecting its bulk viscoelasticity. Accordingly, the mucolytic agent, 4-mercaptobenzoic acid (4-MBA), was encapsulated into PLGA-PEG nanoparticles in order to improve their transmucosal delivery compared to blank PLGA-PEG nanoparticles. Unfortunately, the results showed a fast initial release of 4-MBA, which is considered undesirable in order to facilitate improved retention time of drug carriers and evoke the local only disruption of mucus.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2015
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Karamanidou, Theodora
- Καραμανίδου, Θεοδώρα
Subjects
dc:subject × 19- Aυτο-νανογαλακτωματοποιούμενα συστήματα μεταφοράς φαρμάκων
- Νανοσωματίδια PLGA-PEG
- Ινσουλίνη
- SNEDDS
- ΒΛΕΝΝΑ
- Συστήματα μεταφοράς φαρμάκων
- Βλεννολυτικός παράγοντας
- Self-nanoemulsifying drug delivery systems
- PLGA-PEG nanoparticles
- Insulin
- Mucus
- Drug delivery systems
- Mucolytic agent
- Επιστήμες Μηχανικού και Τεχνολογία
- Επιστήμη Χημικού Μηχανικού
- Νανοτεχνολογία
- Engineering and Technology
- Chemical Engineering
- Nano-Technology
Rights
- Language dc:language
- eng
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/36564